{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:35:30Z","timestamp":1791858930937,"version":"4.3.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Nona and Kullervo V\u00e4re Foundation","award":["20230012"],"award-info":[{"award-number":["20230012"]}]},{"name":"The Helsinki University Hospital Funds","award":["TYH2021234"],"award-info":[{"award-number":["TYH2021234"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-91455-5","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T12:52:01Z","timestamp":1740747121000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Complement activation and vascular complications after pediatric allogeneic hematopoietic stem cell transplantation"],"prefix":"10.1038","volume":"15","author":[{"given":"Lilli","family":"Leimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Vettenranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seppo","family":"Meri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"key":"91455_CR1","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/petr.12723","volume":"20","author":"P Svenberg","year":"2016","unstructured":"Svenberg, P. et al. Improved overall survival for pediatric patients undergoing allogeneic hematopoietic stem cell transplantation \u2013 A comparison of the last two decades. Pediatr. Transpl. 20, 667\u2013674. https:\/\/doi.org\/10.1111\/petr.12723 (2016).","journal-title":"Pediatr. Transpl."},{"key":"91455_CR2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/bmt.2015.250","volume":"51","author":"E Brissot","year":"2016","unstructured":"Brissot, E. et al. Improvement of overall survival after allogeneic hematopoietic stem cell transplantation for children and adolescents: a three-decade experience of a single institution. Bone Marrow Transpl. 51, 267\u2013272. https:\/\/doi.org\/10.1038\/bmt.2015.250 (2016).","journal-title":"Bone Marrow Transpl."},{"key":"91455_CR3","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1200\/jco.2012.46.6193","volume":"31","author":"T Hahn","year":"2013","unstructured":"Hahn, T. et al. Significant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of unrelated donors. J. Clin. Oncol. 31, 2437\u20132449. https:\/\/doi.org\/10.1200\/jco.2012.46.6193 (2013).","journal-title":"J. Clin. Oncol."},{"key":"91455_CR4","doi-asserted-by":"publisher","first-page":"e13158","DOI":"10.1111\/petr.13158","volume":"22","author":"A 4 Zaucha-Prazmo","year":"2018","unstructured":"4 Zaucha-Prazmo, A. et al. Transplant-related mortality and survival in children with malignancies treated with allogeneic hematopoietic stem cell transplantation. A multicenter analysis. Pediatr. Transpl. 22, e13158. https:\/\/doi.org\/10.1111\/petr.13158 (2018).","journal-title":"Pediatr. Transpl."},{"key":"91455_CR5","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/bjh.18176","volume":"198","author":"FR Achini-Gutzwiller","year":"2022","unstructured":"Achini-Gutzwiller, F. R., Snowden, J. A., Corbacioglu, S. & Greco, R. Haematopoietic stem cell transplantation for severe autoimmune diseases in children: A review of current literature, registry activity and future directions on behalf of the autoimmune diseases and paediatric diseases working parties of the European society for blood and marrow transplantation. Br. J. Haematol. 198, 24\u201345. https:\/\/doi.org\/10.1111\/bjh.18176 (2022).","journal-title":"Br. J. Haematol."},{"key":"91455_CR6","doi-asserted-by":"publisher","first-page":"e14239","DOI":"10.1111\/petr.14239","volume":"26","author":"C Oikonomopoulou","year":"2022","unstructured":"Oikonomopoulou, C. et al. Allogeneic hematopoietic stem cell transplantation in infants is associated with significant morbidity and mortality. Pediatr. Transpl. 26, e14239. https:\/\/doi.org\/10.1111\/petr.14239 (2022).","journal-title":"Pediatr. Transpl."},{"key":"91455_CR7","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s00432-022-04021-1","volume":"149","author":"A Grain","year":"2023","unstructured":"Grain, A. et al. Hematopoietic stem cell transplantation for acute lymphoblastic leukemia: why do adolescents and young adults outcomes differ from those of children? A retrospective study on behalf of the Francophone society of stem cell transplantation and cellular therapy (SFGM-TC). J. Cancer Res. Clin. Oncol. 149, 1473\u20131483. https:\/\/doi.org\/10.1007\/s00432-022-04021-1 (2023).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"91455_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1182\/bloodadvances.2020003455","volume":"5","author":"CE Dandoy","year":"2020","unstructured":"Dandoy, C. E. et al. A pragmatic multi-institutional approach to Understanding transplant-associated thrombotic microangiopathy after stem cell transplant. Blood Adv. 5, 1\u201311. https:\/\/doi.org\/10.1182\/bloodadvances.2020003455 (2020).","journal-title":"Blood Adv."},{"key":"91455_CR9","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3389\/fped.2019.00133","volume":"7","author":"CC Dvorak","year":"2019","unstructured":"Dvorak, C. C., Higham, C. & Shimano, K. A. Transplant-associated thrombotic microangiopathy in pediatric hematopoietic cell transplant recipients: a practical approach to diagnosis and management. Front. Pediatr. 7, 133. https:\/\/doi.org\/10.3389\/fped.2019.00133 (2019).","journal-title":"Front. Pediatr."},{"key":"91455_CR10","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.blre.2014.11.001","volume":"29","author":"S Jodele","year":"2015","unstructured":"Jodele, S. et al. A new paradigm: diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury. Blood Rev. 29, 191\u2013204. https:\/\/doi.org\/10.1016\/j.blre.2014.11.001 (2015).","journal-title":"Blood Rev."},{"issue":"Suppl 4","key":"91455_CR11","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1002\/ajh.26872","volume":"98","author":"S Jodele","year":"2023","unstructured":"Jodele, S. & Sabulski, A. Reeling in complement in transplant-associated thrombotic microangiopathy: you\u2019re going to need a bigger boat. Am. J. Hematol. 98 (Suppl 4), S57\u2013s73. https:\/\/doi.org\/10.1002\/ajh.26872 (2023).","journal-title":"Am. J. Hematol."},{"key":"91455_CR12","doi-asserted-by":"publisher","unstructured":"Mez\u00f6, B. et al. Validation of early increase in complement activation marker sC5b-9 as a predictive biomarker for the development of thrombotic microangiopathy after stem cell transplantation. Front. Med. 7 https:\/\/doi.org\/10.3389\/fmed.2020.569291 (2020).","DOI":"10.3389\/fmed.2020.569291"},{"key":"91455_CR13","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.bbmt.2018.01.009","volume":"24","author":"O Horv\u00e1th","year":"2018","unstructured":"Horv\u00e1th, O. et al. Early increase in complement terminal pathway activation marker sC5b-9 is predictive for the development of thrombotic microangiopathy after stem cell transplantation. Biol. Blood Marrow Transpl. 24, 989\u2013996. https:\/\/doi.org\/10.1016\/j.bbmt.2018.01.009 (2018).","journal-title":"Biol. Blood Marrow Transpl."},{"key":"91455_CR14","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1002\/ajh.27030","volume":"98","author":"AB Notarantonio","year":"2023","unstructured":"Notarantonio, A. B. et al. Systemic complement activation influences outcomes after allogeneic hematopoietic cell transplantation: A prospective French multicenter trial. Am. J. Hematol. 98, 1559\u20131570. https:\/\/doi.org\/10.1002\/ajh.27030 (2023).","journal-title":"Am. J. Hematol."},{"key":"91455_CR15","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41409-022-01607-8","volume":"57","author":"L Leimi","year":"2022","unstructured":"Leimi, L., Jahnukainen, K., Olkinuora, H., Meri, S. & Vettenranta, K. Early vascular toxicity after pediatric allogeneic hematopoietic stem cell transplantation. Bone Marrow Transpl. 57, 705\u2013711. https:\/\/doi.org\/10.1038\/s41409-022-01607-8 (2022).","journal-title":"Bone Marrow Transpl."},{"key":"91455_CR16","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/leu.2017.265","volume":"32","author":"N Toft","year":"2018","unstructured":"Toft, N. et al. Results of NOPHO ALL2008 treatment for patients aged 1\u201345 years with acute lymphoblastic leukemia. Leukemia 32, 606\u2013615. https:\/\/doi.org\/10.1038\/leu.2017.265 (2018).","journal-title":"Leukemia"},{"key":"91455_CR17","unstructured":"NOPHO & NOPHO-DBH AML 2012 protocol research study for treatment of children and adolescents with acute myeloid leukaemia 0\u201318 years. EU Clin.  Trials Register  https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/search?query=2012-002934-35 (2013)."},{"key":"91455_CR18","unstructured":"Heyman, M. A. Treatment study protocol for participants 0\u201345 years with acute lymphoblastic leukaemia. EU Clin. Trials Register  https:\/\/clinicaltrials.gov\/study\/NCT04307576 (2020)."},{"key":"91455_CR19","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Glucksberg","year":"1974","unstructured":"Glucksberg, H. et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 18, 295\u2013304. https:\/\/doi.org\/10.1097\/00007890-197410000-00001 (1974).","journal-title":"Transplantation"},{"key":"91455_CR20","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1182\/bloodadvances.2019000143","volume":"3","author":"S Pagliuca","year":"2019","unstructured":"Pagliuca, S. et al. Allogeneic reactivity-mediated endothelial cell complications after HSCT: a plea for consensual definitions. Blood Adv. 3, 2424\u20132435. https:\/\/doi.org\/10.1182\/bloodadvances.2019000143 (2019).","journal-title":"Blood Adv."},{"key":"91455_CR21","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/bmt.2017.161","volume":"53","author":"S Corbacioglu","year":"2018","unstructured":"Corbacioglu, S. et al. Diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation. Bone Marrow Transpl. 53, 138\u2013145. https:\/\/doi.org\/10.1038\/bmt.2017.161 (2018).","journal-title":"Bone Marrow Transpl."},{"key":"91455_CR22","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1097\/TP.0b013e3181f24e8d","volume":"90","author":"BS Cho","year":"2010","unstructured":"Cho, B. S. et al. Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation. Transplantation 90, 918\u2013926. https:\/\/doi.org\/10.1097\/TP.0b013e3181f24e8d (2010).","journal-title":"Transplantation"},{"key":"91455_CR23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jtct.2022.11.015","volume":"29","author":"ML Schoettler","year":"2023","unstructured":"Schoettler, M. L. et al. Harmonizing definitions for diagnostic criteria and prognostic assessment of transplantation-associated thrombotic microangiopathy: A report on behalf of the European society for blood and marrow transplantation, American society for transplantation and cellular therapy, Asia-Pacific blood and marrow transplantation group, and center for international blood and marrow transplant research. Transpl. Cell. Ther. 29, 151\u2013163. https:\/\/doi.org\/10.1016\/j.jtct.2022.11.015 (2023).","journal-title":"Transpl. Cell. Ther."},{"key":"91455_CR24","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/s41409-020-0818-4","volume":"55","author":"T Nava","year":"2020","unstructured":"Nava, T. et al. Supportive care during pediatric hematopoietic stem cell transplantation: beyond infectious diseases. A report from workshops on supportive care of the pediatric diseases working party (PDWP) of the European society for blood and marrow transplantation (EBMT). Bone Marrow Transpl. 55, 1126\u20131136. https:\/\/doi.org\/10.1038\/s41409-020-0818-4 (2020).","journal-title":"Bone Marrow Transpl."},{"key":"91455_CR25","doi-asserted-by":"crossref","unstructured":"Jodele, S. et al. Transplantation-associated thrombotic microangiopathy risk stratification: is there a window of opportunity to improve outcomes? Transpl. Cell. Ther. 28  392.e391-392.e399 (2022).","DOI":"10.1016\/j.jtct.2022.04.019"},{"key":"91455_CR26","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1182\/bloodadvances.2020003988","volume":"5","author":"CS Higham","year":"2021","unstructured":"Higham, C. S. et al. Transplant-associated thrombotic microangiopathy in pediatric patients: pre-HSCT risk stratification and prophylaxis. Blood Adv. 5, 2106\u20132114. https:\/\/doi.org\/10.1182\/bloodadvances.2020003988 (2021).","journal-title":"Blood Adv."},{"key":"91455_CR27","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1182\/bloodadvances.2019001315","volume":"4","author":"R Elfeky","year":"2020","unstructured":"Elfeky, R. et al. New insights into risk factors for transplant-associated thrombotic microangiopathy in pediatric HSCT. Blood Adv. 4, 2418\u20132429. https:\/\/doi.org\/10.1182\/bloodadvances.2019001315 (2020).","journal-title":"Blood Adv."},{"key":"91455_CR28","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1182\/blood-2015-08-663435","volume":"127","author":"S Jodele","year":"2016","unstructured":"Jodele, S. et al. The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy. Blood 127, 989\u2013996. https:\/\/doi.org\/10.1182\/blood-2015-08-663435 (2016).","journal-title":"Blood"},{"key":"91455_CR29","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1038\/s41409-021-01283-0","volume":"56","author":"JA Young","year":"2021","unstructured":"Young, J. A., Pallas, C. R. & Knovich, M. A. Transplant-associated thrombotic microangiopathy: theoretical considerations and a practical approach to an unrefined diagnosis. Bone Marrow Transpl. 56, 1805\u20131817. https:\/\/doi.org\/10.1038\/s41409-021-01283-0 (2021).","journal-title":"Bone Marrow Transpl."},{"key":"91455_CR30","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1055\/s-0039-1692721","volume":"119","author":"E Gavriilaki","year":"2019","unstructured":"Gavriilaki, E. et al. Linking complement activation, coagulation, and neutrophils in transplant-associated thrombotic microangiopathy. Thromb. Haemost  119, 1433\u20131440. https:\/\/doi.org\/10.1055\/s-0039-1692721 (2019).","journal-title":"Thromb. Haemost"},{"key":"91455_CR31","doi-asserted-by":"publisher","first-page":"e163","DOI":"10.1016\/j.bbmt.2018.12.840","volume":"25","author":"ML Schoettler","year":"2019","unstructured":"Schoettler, M. L., Lehmann, L., Li, A., Ma, C. & Duncan, C. Thrombotic microangiopathy following pediatric autologous hematopoietic cell transplantation: A report of significant End-Organ dysfunction in eculizumab-treated survivors. Biol. Blood Marrow Transpl. 25, e163\u2013e168. https:\/\/doi.org\/10.1016\/j.bbmt.2018.12.840 (2019).","journal-title":"Biol. Blood Marrow Transpl."},{"key":"91455_CR32","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1007\/s00277-017-3092-9","volume":"96","author":"J Qi","year":"2017","unstructured":"Qi, J. et al. Plasma levels of complement activation fragments C3b and sC5b-9 significantly increased in patients with thrombotic microangiopathy after allogeneic stem cell transplantation. Ann. Hematol. 96, 1849\u20131855. https:\/\/doi.org\/10.1007\/s00277-017-3092-9 (2017).","journal-title":"Ann. Hematol."},{"key":"91455_CR33","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1182\/blood-2013-12-547067","volume":"123","author":"SR Cataland","year":"2014","unstructured":"Cataland, S. R., Holers, V. M., Geyer, S., Yang, S. & Wu, H. M. Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiate aHUS from TTP. Blood 123, 3733\u20133738. https:\/\/doi.org\/10.1182\/blood-2013-12-547067 (2014).","journal-title":"Blood"},{"key":"91455_CR34","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1182\/blood-2014-03-564997","volume":"124","author":"S Jodele","year":"2014","unstructured":"Jodele, S. et al. Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults. Blood 124, 645\u2013653. https:\/\/doi.org\/10.1182\/blood-2014-03-564997 (2014).","journal-title":"Blood"},{"key":"91455_CR35","doi-asserted-by":"publisher","first-page":"1064203","DOI":"10.3389\/fimmu.2022.1064203","volume":"13","author":"ML Schoettler","year":"2023","unstructured":"Schoettler, M. L., Bhatt, H. & Vasu, S. A systematic review of diagnostic, prognostic, and risk blood and urine biomarkers of transplant-associated thrombotic microangiopathy. Front. Immunol. 13, 1064203. https:\/\/doi.org\/10.3389\/fimmu.2022.1064203 (2023).","journal-title":"Front. Immunol."},{"key":"91455_CR36","doi-asserted-by":"publisher","unstructured":"Ekdahl, K. N. et al. Interpretation of serological complement biomarkers in disease. Front. Immunol. 9 https:\/\/doi.org\/10.3389\/fimmu.2018.02237 (2018).","DOI":"10.3389\/fimmu.2018.02237"},{"key":"91455_CR37","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jtct.2023.12.151","volume":"30","author":"ML Schoettler","year":"2024","unstructured":"Schoettler, M. L. et al. Elevated C3 is predictive, diagnostic and prognostic in pediatric transplant associated thrombotic microangiopathy- a prospective study. Transpl. Cell. Ther. 30, 94\u2013S95. https:\/\/doi.org\/10.1016\/j.jtct.2023.12.151 (2024).","journal-title":"Transpl. Cell. Ther."},{"key":"91455_CR38","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1093\/ckj\/sfaa195","volume":"14","author":"M Blasco","year":"2021","unstructured":"Blasco, M. et al. Thrombotic microangiopathies assessment: Mind the complement. Clin. Kidney J. 14, 1055\u20131066. https:\/\/doi.org\/10.1093\/ckj\/sfaa195 (2021).","journal-title":"Clin. Kidney J."},{"key":"91455_CR39","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1159\/000529734","volume":"48","author":"C Wijaya","year":"2023","unstructured":"Wijaya, C. et al. Measurement of complement activation via Plasma-Soluble C5b-9 comparison with terminal complement complex staining in a series of kidney biopsies. Kidney Blood Press. Res. 48, 220\u2013230. https:\/\/doi.org\/10.1159\/000529734 (2023).","journal-title":"Kidney Blood Press. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91455-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91455-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91455-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T12:52:06Z","timestamp":1740747126000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91455-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["91455"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-91455-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,27]]},"assertion":[{"value":"8 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7073"}}